From nanotechnology to AI: The next generation of CRISPR-based smart biosensors for infectious disease detection
Authors:
- IrkhamIRIrkham
- Abdullahi Umar IbrahimAIAbdullahi Umar Ibrahim
- Chidi Wilson NwekwoCNChidi Wilson Nwekwo
- Pwadubashiyi Coston PwavodiPPPwadubashiyi Coston Pwavodi
- Salma Nur ZakiyyahSalma Nur Zakiyyah
- Mehmet OzsozMOMehmet Ozsoz
- Yeni Wahyuni HartatiYHYeni Wahyuni Hartati
- 25 December 2024
- journal article
- review article
- Published by Elsevier in Microchemical Journal
- Vol. 208
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- The importance, benefits, and future of nanobiosensors for infectious diseasesBiotechnology and Applied Biochemistry, 2024
- A Review of CRISPR-Based Advances in Dermatological DiseasesMolecular Diagnosis & Therapy, 2023
- Recent Advances in CRISPR-Cas Technologies for Synthetic BiologyJournal of Microbiology, 2023
- Opportunities and challenges with CRISPR-Cas mediated homologous recombination based precise editing in plants and animalsPlant Molecular Biology, 2022
- CRISPR/Cas System Toward the Development of Next-Generation Recombinant Vaccines: Current Scenario and Future ProspectsArabian Journal for Science and Engineering, 2022
- An Insight into Modern Targeted Genome-Editing Technologies with a Special Focus on CRISPR/Cas9 and its ApplicationsMolecular Biotechnology, 2022
- Exploring nano-enabled CRISPR-Cas-powered strategies for efficient diagnostics and treatment of infectious diseasesJournal of Nanostructure in Chemistry, 2022
- CRISPR-based strategies in infectious disease diagnosis and therapyInfection, 2021
- Futuristic CRISPR-based biosensing in the cloud and internet of things era: an overviewMultimedia Tools and Applications, 2020
- Surface modification methods for electrochemical biosensors2019